loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Drug Master Files (DMF) for 21517 Active Pharmaceutical Ingredient (API) submitted to the U.S. FDA. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Biovectra Inc

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 Biovectra Inc (1)

    filter

    01 DOCETAXEL (1)

    filter

    01 Canada (1)

    filter

    01 Active (1)

    filter

    01 Blank (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    BIOVECTRA INC

    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Canada
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    DOCETAXEL

    PDF Supplier PDF
    URL Supplier Web Content
    21517
    Active
    2008-04-09
    N/A
    II
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for Drug Master Files (DMF) for 21517 of Biovectra Inc

    Looking for Drug Master Files (DMF) for 21517 of Biovectra Inc 1

    20

    Biovectra Inc, based in Canada, is a pharmaceutical company that stands out with its certifications from FDA.

    One of their notable products is DOCETAXEL, with a corresponding US DMF Number 21517.

    Remarkably, this DMF maintains an Active status since its submission on April 09, 2008, highlighting commitment to regulatory compliance.

    Post Enquiry
    POST ENQUIRY